Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Tekcapital Plc LSE:TEK London Ordinary Share GB00BKXGY798 ORD �0.004
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.75 8.43% 22.50 22.00 23.00 22.75 20.75 21.00 3,307,029 15:43:18
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 5.4 3.6 8.1 3.0 29

Tekcapital Share Discussion Threads

Showing 1651 to 1674 of 1850 messages
Chat Pages: 74  73  72  71  70  69  68  67  66  65  64  63  Older
DateSubjectAuthorDiscuss
07/5/2021
08:13
20p coming soon and still well below the old NAV of 25p in results a few days ago Which this RNS today has now made obsolete as the NAV has now grown with the Belluscura news More news from Belluscura in the coming weeks should only increase the NAV further imo dyor
buywell2
07/5/2021
08:08
The Belluscura technology looks superb from what buywell has read ( see back posts here ) The timing to market could not have been scripted better as the product answers a worldwide problem A shortage of oxygen for sick people which Covid-19 is exacerbating by the day One can only think that the AIM float will go very well IMHO Well done Clifford , buywell is impressed
buywell2
07/5/2021
07:39
Holding in Belluscura valued at £8-10m if 48p achieved. Assuming the share doesnt bomb afterwards Tek's holding will be worth anything higher than that in due course
faz
07/5/2021
07:35
Surely these should be trading closer to 20p but people continue to sell in the 11-13p range. Maybe today they let it run up a bit.
matt123d
07/5/2021
07:33
So mcap has 8 million from this. Now at 17 million and other products. Way undervalued
letmepass
07/5/2021
07:06
Belluscura to float on AIM RNS The Company is seeking to raise £15 million via a conditional placing of shares ("Placing") to support the commercial roll-out of the X-PLO₂R and to progress Belluscura's oxygen enrichment product portfolio. Following completion of the Placing and Admission to AIM, Belluscura is expected to be valued in the region of £50-55 million.
buywell2
07/5/2021
01:07
Thank you @Smackeraim, that really was both useful and interesting. I didn't quite realise how much value there was in the the company!
ppmm
06/5/2021
22:00
Also thanks Mr Oz.
royalalbert
06/5/2021
21:25
Thanks for that Smack, interesting to say the least.
royalalbert
06/5/2021
21:15
Just interviewed @tekcapital CEO Dr Clifford Gross who announced they will float or sell their entire portfolio - #Guident #Lucyd #Bellescura #Salarius within 2 years and pay #TEK shareholders a special dividend. Please view here/retweet: hTTps://youtu.be/2Qao6EW-4nY https://twitter.com/DonaldLeggatt/status/1390356065439686657
smackeraim
06/5/2021
20:29
hTTps://youtu.be/2Qao6EW-4nY Best interview by a mile. Watch to the end. Sees exits from all portfolio companies within 2yrs. Some huge companies in the making imv Guident massive potential, in talks Microsalt, also in talks Belluscura, in production this year Lucyd, in trend
mr.oz
05/5/2021
21:01
buywell has popped on the Lucyd website a few times over the last several weeks since the crowd funding which achieved the maximum allowable amount under the then current rules and regs It seems that the amount of interest that the above attracted , together with the succinct answers that CEO Harrison Gross gave , has garnered both interest in the Lucyd story and sales of the brand , see his answers right at the bottom of this link hTTps://www.startengine.com/innoeye One reason for saying this is : Every single time buywell looked , around 7 or 8 out of the extras that Lucyd sell along with a pair of smart glasses out of the 17 offered for sale ---- were SOLD OUT This included the 3 pairs of polaroid tinted lenses at $29 , which seems an absolute steal imo , as in effect you get three different kinds of 'look' to your sunshades for the same $149 cost of the Lucyd smartglasses/sunglasses ( ie no prescription lenses required ) OR put yet another way --- you scratch your first lenses on some sand on the beach --- you pop out the scratched lenses and pick one of the three spare lenses . A VERY cheap offer that one imo hTTps://lucyd.co. The fact that many differing 'extra' products have been selling out indicates to buywell that sales have been ahead of anticipated sales ---- which has imo been confirmed by what Harrison said in the RNS today : " given the company's growth since the launch of our popular Lucyd® Lyte e-glasses this past January." When buywell looked the other day the 'extra lenses' were back on sale , so they have received another order , but still 7 out of 17 other extras were SOLD OUT. The website is well worth checking out --- note the use of affiliates regarding sales --- this also buywell believes is driving additional sales , however the new sales talent is aimed at getting a BIG company on board to take the Lycyd brand --- so more frames and styles needed and buywell notes also that Lucyd have in fact chosen a variety of names and different frames/colors already ---- presumably with input from the new guys imo dyor hTTps://www.londonstockexchange.com/news-article/TEK/portfolio-company-update-lucyd/14963478 Harrison Gross the Lucyd cofounder and CEO said : "This team expansion is an important step towards our path to market leadership in smart eyewear. It is our belief that these new hires will help catalyze Lucyd's first-mover advantages into a firm position as a technology and style leader in the emerging wearables market. Adding this wealth of optical, sales and content management experience to the team is invaluable, given the company's growth since the launch of our popular Lucyd® Lyte e-glasses this past January." About Lucyd and Innovative Eyewear Inc. Lucyd's mission is to Upgrade your Eyewear® with advanced ergonomic frames that are easy to use, fun to wear, and help you stay safely connected to your digital life. The Lucyd brand and IP portfolio are exclusively licensed to and operated by Innovative Eyewear, Inc. To learn more, or order Lucyd Lyte, please visit hTTps://lucyd.co. Tekcapital currently owns 100% of the share capital of Lucyd Ltd and approximately 75% of the share capital of its U.S. operating subsidiary, Innovative Eyewear, Inc.
buywell2
05/5/2021
10:27
Am now a holder. Some exciting products here!
r9505571
05/5/2021
09:55
I think the seller has finished so should see this climb now on sentiment and news due and there is more liquidity dilution sometimes isnt that bad in the grand scheme of things
mick1909
05/5/2021
08:39
Probably Belluscura news next up
smackeraim
05/5/2021
08:36
Last two trades yesterday Recent Share Trades for TekCapital (TEK) Date Time Trade Prc Volume Buy/Sell Bid Ask Value 04-May-21 16:26:21 12.38 250,000 Buy* 12.00 12.50 30.95k O 04-May-21 15:18:43 12.335 850,000 Buy* 12.00 12.50 104.85k O RNS today on LUCYD So now a sales drive is being sorted to coincide with Vyrb APP release dyor
buywell2
04/5/2021
07:41
Re Guident RNS This company could turn out to be the biggest earner IMO as more states will adopt the lead that Florida have taken regarding control centre requirement One would imagine Guident could soon be signing a contract with an autonomous vehicle operator before very long, perhaps a land based drone delivery operator/provider , probably timed just prior to the opening of the Florida Control Centre which is due imo around july this year
buywell2
30/4/2021
08:13
Plus use of crowdfunding soon to get another TEK patent up and running presumably to replace Belluscura when it gets IPO'd soon Developing four companies at any one time seems a good idea for the present time till Belluscura gets sold.
buywell2
30/4/2021
08:07
https://mobile.twitter.com/BabblerBestBets/status/1388026413945663488
babbler
30/4/2021
08:05
35 cents is over 25p hTtps://fx-rate.net/USD/GBP/ Over 50% discount to NAV with probably the best designed and patented oxygen concentrator currently on the market
buywell2
30/4/2021
07:59
NAV over 20p. Strange it's staying around 12p.
babbler
30/4/2021
07:27
Decent results NAV is now US 35 cents check it here hTtps://fx-rate.net/USD/GBP/ buywell likes these bits: Net assets increased by approximately 45% to US$32.7m, a record level for our Company. Total revenues increased 28% to US$9.9m with unrealised profit on the revaluation of investments driving that increase by US$8.7m. Our after-tax profit increased by 39% to US$7.7m. Next comes either news of Belluscura IPO or news of a deal with a BIG USA brand to use MicroSalt plus the opening of the first Control Cetre for Autonomous land based drones and vehicles in Florida by way of Guident Then the Lucyd APP Vyrb Financial highlights · Net Assets increased 45% to US$32.7m, a record level (2019: US$22.5m) - NAV per share US$0.35 (2019: US$0.35) · Portfolio valuation increased 50% to US$30.5m (2019: US$20.3m) · Total revenue US$9.9m (2019: US$7.7m) - Revenue from services US$1.19m (2019: US$1.20m) - Net increase of US$8.7m in fair value of portfolio companies (2019: US$6.5m) · Profit after tax: US$7.7m (2019: US$5.5m) · Service revenues cover approximately 54% of cost base (cost of sales and operating expenses) · Share placings totalling US$2.6m completed during the period, plus an additional raise of US$5.3m completed post-period end. Dr. Clifford Gross, Executive Chairman said: "Through the collective efforts of our dedicated and capable team we have achieved record results in 2020. Our portfolio companies have demonstrated significant growth and we believe they are well positioned to further expand and achieve meaningful milestones in 2021."
buywell2
30/4/2021
01:12
India ----- and according to CNN cases could be 30 times higher than reported Data from serology surveys supports much higher case numbers it is claimed hTTps://edition.cnn.com/2021/04/27/india/india-covid-underreporting-intl-hnk-dst/index.html Looking at what buywell3 has posted , a truer death rate for Covid-19 would be 3% rather than the 2% on the worldometer website if taken over 180 days from covid infection, that being predominantly from older strain data --- with new variants like UK variant , P1 and South African , fatalities are higher along with transmissibility. With new potentially even worse India variants , it follows that deaths from long COVID which in hospitalized Covid patients in the last buywell3 post , equated to another 2.9% or circa 5% if it was added to the worldometer death rate. Countries are using different criteria for putting death by Covid-19 on a death certificate --- if the WHO or CDC or some other body were to include deaths within 6 months of infection , the death rate is most likely imo heading towards 6% with current known VOC and VOI mutated covid types. This under reporting seems to know now bounds dyor
buywell2
29/4/2021
21:50
The link that follows , shows the results on the largest medical study carried out on patients that have had Covid-19 , with 30 day and various other follow ups out to 180 days , titled: High-dimensional characterization of post-acute sequalae of COVID-19 Published 22nd April 2021 hTtps://www.nature.com/articles/s41586-021-03553-9_reference.pdf The study showed that after the first 30 days of illness COVID-19 survivors then had an almost 60% increased risk of death over the following six months compared with the general population. At 180 days excess deaths among all COVID-19 survivors were estimated at eight people per 1,000 patients. But this rose among those that had been hospitalized with COVID-19 and who survived beyond the first 30 days of illness, to 29 excess deaths per 1,000 patients over the following six months. Dr. Ziyad Al-Aly, assistant professor of medicine at the Washington University School of Medicine and senior author of the study said “It is not an exaggeration to say that long COVID-19 — the long-term health consequences of COVID-19 — is America’s next big health crisis.” “The lingering effects of the disease will be felt for many years and even decades,” Al-Aly said. The best data to date IMO dyor
buywell3
Chat Pages: 74  73  72  71  70  69  68  67  66  65  64  63  Older
ADVFN Advertorial
Your Recent History
LSE
TEK
Tekcapital
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210731 12:01:14